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Abstract Gln 313 and His 332 residues in the active centre of 
NAD+-dependent formate dehydrogenase (EC 1.2.1.2, FDH) 
from the bacterium Pseudomonas sp. 101 are conserved in all 
FDHs and are equivalent o the glutamate-histidine pair in active 
sites of D-specific 2-hydroxyacid dehydrogenases. Two mutants 
of formate dehydrogenase from Pseudomonas sp. 101, Gln313Glu 
and His332phe, have been obtained and characterised. The 
Gln313Glu mutation shifts the pK of the group controlling 
formate binding from less than 5.5 in wild-type enzyme to 7.6 
thus indicating that Gin 313 is essential for the broad pH affinity 
profile towards substrate. His332phe mutation leads to a 
complete loss of enzyme activity. The His33ZPhe mutant is still 
able to bind coenzyme but not substrate or analogues. The role of 
histidine in the active centre of FDH is discussed. The 
protonation state of His 332 is not critical for catalysis but vital 
for substrate binding. A partial positive charge on the histidine 
imldazole, required for substrate binding, is provided via tight H- 
bond to the Gin 313 carboxamide. 
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1. Introduction 
NAD+-dependent formate dehydrogenase (EC 1.2.1.2, 
FDH) from the methylotrophic bacterium Pseudomonas sp. 
101 is a member of the family of D-specific 2-hydroxyacid 
dehydrogenases acting on o-stereoisomers of the respective 
substrates. There is strong sequence similarity between FDH 
and these dehydrogenases [1]. Crystal structures of FDH [2] 
and two D-specific dehydrogenases, D-phosphoglycerate dehy- 
drogenase [3] and o-glycerate dehydrogenase [4], revealed sig- 
nificant similarities in the three-dimensional fold of these pro- 
teins. 
The imidazole moiety of histidine is a ubiquitous acid-base 
catalyst found in a number of enzymes. One of the classic 
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examples is the proton relay system comprising the serine- 
histidine-aspartate triad in serine proteases [5]. Acid-base cat- 
alysis is an important feature of a number of NAD+-depend - 
ent dehydrogenases acting on 2-hydroxyacids [6-8]. An invar- 
iant pair of residues, histidine and a carboxylic acid, 
occupying conserved positions is found in the active centres 
of a number of D- and L-specific dehydrogenases [9]. They 
function as a composite acid-base catalyst facilitating proton 
transfer to and from the 2-hydroxylic group of the substrate 
[1,3,4,6-9]. 
Comparison of the three-dimensional structures of NAD ÷- 
dependent dehydrogenases with that of FDH [10] showed that 
His 332 (FDH numbering) is the 'essential' histidine residue, 
while Gln 313 substitutes for the conserved carboxylate. 
Replacement of glutamate for glutamine is highly specific 
and conserved throughout all known FDH sequences [11]. 
The glutamine residue is located within the Pro-Gln-Pro- 
Ala-Pro fingerprint. In FDH the two prolines flanking 
Gln 313 are in the cis-conformation a d force the amide group 
of the glutamine to face His 332 NE2. As a result of this inter- 
action His 332 forms a tight H-bond (2.8 A) with Gln 313 NE2 
and is trapped in a non-protonated state [2,10,11]. 
A schematic view of the FDH active centre is presented in 
Fig. 1. Three amino acid residues in the vicinity of the cata- 
lytic C4 position of the nicotinamide moiety of NAD +, 
Asn 146, Arg 2s4 and His 332, can be involved in substrate bind- 
ing. In the FDH-NAD+-azide crystal structure Arg 284 and 
Asn 146 are directly involved in binding azide, the closest struc- 
tural and electronic analogue of the CO2 molecule, the prod- 
uct of the reaction [12]. On this basis it was proposed that the 
substrate binding site overlaps with that for azide and that 
formate anion binds to FDH via two hydrogen bonds to 
Arg 284 and Asn 146 [2,11]. This was further corroborated by 
Arg 2s4 mutagenesis studies in FDH (Galkin, A., unpublished 
data) and comparison with the known three-dimensional 
structures of a number of D- and L-specific dehydrogenases 
of 2-hydroxyacids which contain a conserved arginine residue 
responsible for binding the carboxylate group of the substrate 
[2-4]. The role of His 332 in FDH remains omewhat unclear. 
Computer modeling suggests that His 332 may bind substrate 
giving rise to equally good geometry of the putative transition 
state complex [1 1] although this is not evident from the FDH- 
NAD+-azide crystal structure [2]. 
The goal of the present work was to investigate the role of 
His 332 and Gln 313 in FDH catalysis and the implication of 
'locking' of His 332 in only one protonation state. 
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Fig. 1. Schematic diagram of the active centre of formate dehydrogenase from Pseudomonas sp. 101. Side chains shown are those of the resi- 
dues involved in formate binding. The nicotinamide moiety of NAD + is shown. H-bonds are indicated by dashed lines. 
2. Materials and methods 
2.1. Materials 
All chemicals used for genetic engineering manipulations were of 
molecular biology grade (Sigma). T4 polynucleotide kinase, T4 DNA 
polymerase and ligase were from New England Biolabs. Oligonucleo- 
tides were prepared with an Applied Biosystems DNA Synthesizer 
380B. NAD + (grade V), NADH (grade IV), sodium azide (Sigma) 
and sodium formate (analytical grade, Reachim, Russia) were used 
in kinetic and spectrofluorimetric experiments. 
2.2. Methods 
2.2.1. Mutant preparation Uracil single stranded plasmid pFDH6 
was prepared according to [13]. The plasmid pFDH6 was obtained by 
cloning the BamHI-EcoRI fragment containing the FDH gene and tac 
promoter, from the plasmid pFDH4 [14] to the phagemid pUC119. 
Site-directed mutagenesis reactions were performed using phosphory- 
lated 25-met 5'-CGGCGCCGGCTCCGGAAACCACACG-Y and 
23-mer 5'-GCCGGAGATGAACGGGGTCATGC-3' primers to pro- 
duce GlnalaGlu and His3a2Phe mutations, respectively. The E. cob 
TG1 cell line was used for the transformation by the reaction prod- 
ucts. Screening of mutants was performed by DNA sequencing with 
an Applied Biosystems Automated DNA Sequencer 370A and a PCR 
Taq dye-labeled terminators equencing kit. The mutants were ex- 
pressed in E. coli TG1 cells and purified as for wild-type recombinant 
enzyme [14]. The concentration of inactive His3a2Phe mutant enzyme 
was measured by ELISA as described in [15]. 
2.2.2. Characterisation of  mutants Vm0~ and Km for wild-type and 
Gln313Glu FDH were measured in 0.1 M sodium phosphate, Tris-HC1 
and sodium pyrophosphate buffers by varying the concentration of 
one of the corresponding substrates at the saturating concentration of
the second as described earlier [16]. Spectrofluorimetric determination 
of binding of NAD ÷ and azide to wild-type and Hisaa2Phe FDH were 
carried out according to [17]. 
3. Results and discussion 
Crystallographic studies do not exclude the possibility of 
His 332 being involved in substrate binding [2]. To bind for- 
mate anion efficiently His a32 imidazole should carry a positive 
charge while high resolution crystal structures unambiguously 
reveal that His aa2 protonation is hindered because of the tight 
H-bond to the conserved Gln a13. Moreover the involvement of 
histidine is not supported by the pH profiles of kinetic param- 
eters. Maximal reaction rate, defined by the rate of hydride 
ion transfer [16,18], is constant within the whole range of 
enzyme pH stability (5.5-11.2), while the affinity for substrate, 
substrate analogues and coenzyme simultaneously decreases at 
pHs higher than 10 with an apparent pK of 10.5 + 0.2. This 
has been attributed to a protein conformational change (Me- 
sentsev, A., unpublished ata). 
Fig. 2 presents the expected shifts in the acid-base proper- 
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Fig. 2, Protonation of the histidine imidazole: (left) H-bonded to an amide group; (middle) isolated; (right) H-bonded to a carboxylate group. 
ties of a histidine H-bonded to a carboxylate group of aspar- 
tare or glutamate (as in D- and L-specific dehydrogenases, 
respectively) or glutamine (as in FDH) compared to the iso- 
lated imidazole group of a non-H-bonded histidine. Usually 
the imidazole of histidines in proteins is characterised by a pK 
of 6.4-7.2 [19]. Pairing to a carboxylate group of a glutamic 
or aspartic acid shifts the acid-base quilibrium towards the 
protonated state of histidine, making it a stronger base and 
thus increasing its pK. In contrast, the counterpart (glutamate 
or aspartate) becomes a stronger acid. H-bonding to a more 
basic group, e.g. the amide of glutamine, stabilises the imida- 
zole moiety in the non-protonated state and lowers its pK. 
The tight H-bond between His 332 and Gln 313 NE2 shifts the 
pK of the histidine to the acidic side, probably far beyond the 
pH range in which the enzyme is stable (5.5). A partial proton 
transfer from glutamine to histidine induces a positive charge 
on the imidazole and facilitates negatively charged formate 
binding. This plays an important role in the mechanism. 
The stronger the partial charge, the stronger formate binding 
should be. Fully protonated His 332 (a HisH+/Glu - ion pair) 
would be the best ligand for formate. Absence of a (partial) 
positive charge would hinder formate binding. Mutation of 
His 332 to any residue without the ability to form H-bonds is 
thus expected to destroy formate binding. 
The histidine and glutamine residues in the FDH active site 
were replaced by phenylalanine and glutamate, respectively. 
The first mutation is expected to preserve the overall active 
site architecture but does not allow H-bonding to other 
groups. Mutation of Gin 31a to glutamate should release the 
'protonation lock' imposed onto His 332. The results are pre- 
sented in Table 1 and Figs. 3 and 4. 
The His332Phe mutant has no catalytic activity, attributed 
to loss of ability to bind substrate. The mutant does not bind 
azide, the strongest inhibitor competitive to formate. It is 
revealed by a lack of quenching of the protein tryptophan 
fluorescence while formation of the FDH-NAD+-azide com- 
plex [17] (Fig. 3). In contrast azide strongly binds to wild-type 
FDH-NAD ÷. According to experiments on quenching of pro- 
tein fluorescence by coenzyme (Table 1), the His332Phe mutant 
has nearly the same affinity for NAD + as wild-type FDH. 
This indicates that any possible changes in the structure of 
the active centre are local and do not extend to the coenzyme 
binding subsite. 
The mutation Glna13Glu results in the predicted effects on 
FDH kinetic parameters (Table 1). The mutant has the same 
catalytic activity as the wild type and the same affinity for 
coenzyme. The mutant showed stronger formate binding 
than the wild type in the pH range 6.0-7.0 where His 332 is 
expected to be protonated (Table 1, Fig. 4). There is a new pH 
transition for Km for formate with a pK of 7.6 + 0.2 (Fig. 4). 
The value of the pK is very close to that expected for a 
histidine H-bonded to a carboxylate (Fig. 2). The pH transi- 
Table 1 
Kinetic properties of wild-type and mutant formate dehydrogenases (pH 7.0, 37°C) 
Enzyme kcat gm f°rmate g i  azide gm NAD gb NAD 
(% to wild type) (mM) (I.tM) (mM) (mM) a 
wild-type FDH 100 7 0.15 0.07 0.5 
His332Phe 0 no binding - 1.2 
Gln313Glu 100 4 n.d. b 0.07 n.d. 
aKdNAD was determined by quenching of the protein tryptophan fluorescence as described in [17]. 
bn.d., not determined. 
V.I. Tishkov et al.IFEBS Letters 390 (1996) 104-108 107 
tion is likely to be a result of the 'unlocking' of His 332 and its 
H-bonding to the carboxylate group of Glu 313. Thus, the 
Gln313Glu mutation affects the binding of formate to the ac- 
tive site due to change of the pK of His 332. Since formate 
anion is bound, the protonation state of His 332 seems not to 
be essential for catalysis. Both the wild type and the 
Gln313Glu mutant show the same catalytic activity within a 
wide range of pHs (Fig. 4). 
The high degree of conservation of Gln 313 and the 'finger- 
print' sequence pattern in FDHs from various organisms sug- 
gest an important role for this residue. It provides an extreme- 
ly low pK and a partial positive charge on its counterpart, the 
His 332 imidazole. The affinity of the Gln313Glu mutant o- 
wards substrates i  slightly superior to the wild type at neutral 
pH but rapidly decreases at basic pH. The optimum pH range 
for substrate binding for wild-type FDH is much broader 
(5.5-10.5) thus increasing the viability of the cell under un- 
favourable nvironmental conditions. 
4. Conclusions 
Previously it was suggested that one of the formate ligands 
is the guanidinium group of Arg 284 [2,11]. Several ines of 
evidence confirm this assumption, including (a) the X-ray 
structures [2], (b) comparison with known three-dimensional 
structures of a number of D- and L-specific dehydrogenases of 
2-hydroxyacids where a conservative arginine residue binds 
the carboxylate group of the substrate [10] and (c) Arg 2s4 
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Fig. 3. Quenching of the tryptophan fluorescence of wild-type FDH 
(i) and the HisZZ2phe mutant (O) in the presence of NAD + 
(6×10 -4 M) as a function of azide concentration. Measurements 
were carried out in 0.1 M potassium phosphate, pH 7.0 at 37°C. 
Enzyme concentration was 4.4X 10 -6 M. Exitation wavelength 300 
nm, emission wavelength 343 nm. 
mutagenesis studies in FDH (Galkin, A., unpublished data). 
However, the position of the formate anion in the active site 
remains uncertain. On the basis of the FDH-NAD+-azide 
crystal structure the hypothetical formate binding site can 
only be that of the azide, i.e. between Arg zs4 and Asn 146 
side chains (Fig. 1). There is not enough room between 
Arg 284 and His 332 for the formate anion and the large altera- 
tions in the local conformation of the active site residues are 
required to accommodate he substrate at this position and 
allow H-bonding to His 33z. 
As shown in the present study, the protonation state of 
His zsz is not critical for catalysis but vital for substrate bind- 
ing. Thus His 332, as the putative third substrate ligand, seems 
to provide favourable lectrostatic interaction, in addition to 
H-bonds formed between formate and Arg 284 and Asn 146 side 
chains. Further structural studies of formate containing com- 
plexes are required to localise the substrate binding site and to 
draw more detailed conclusions about FDH mechanism. 
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